1. Home
  2. UPXI vs RGC Comparison

UPXI vs RGC Comparison

Compare UPXI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPXI
  • RGC
  • Stock Information
  • Founded
  • UPXI 2018
  • RGC 2014
  • Country
  • UPXI United States
  • RGC Hong Kong
  • Employees
  • UPXI N/A
  • RGC N/A
  • Industry
  • UPXI Medicinal Chemicals and Botanical Products
  • RGC Medicinal Chemicals and Botanical Products
  • Sector
  • UPXI Health Care
  • RGC Health Care
  • Exchange
  • UPXI Nasdaq
  • RGC Nasdaq
  • Market Cap
  • UPXI 356.9M
  • RGC 377.5M
  • IPO Year
  • UPXI 2021
  • RGC 2021
  • Fundamental
  • Price
  • UPXI $10.95
  • RGC $609.10
  • Analyst Decision
  • UPXI
  • RGC
  • Analyst Count
  • UPXI 0
  • RGC 0
  • Target Price
  • UPXI N/A
  • RGC N/A
  • AVG Volume (30 Days)
  • UPXI 542.9K
  • RGC 87.4K
  • Earning Date
  • UPXI 05-16-2025
  • RGC 06-20-2025
  • Dividend Yield
  • UPXI N/A
  • RGC N/A
  • EPS Growth
  • UPXI N/A
  • RGC N/A
  • EPS
  • UPXI N/A
  • RGC N/A
  • Revenue
  • UPXI $16,562,327.00
  • RGC N/A
  • Revenue This Year
  • UPXI $299.03
  • RGC N/A
  • Revenue Next Year
  • UPXI N/A
  • RGC N/A
  • P/E Ratio
  • UPXI N/A
  • RGC N/A
  • Revenue Growth
  • UPXI 1378.83
  • RGC N/A
  • 52 Week Low
  • UPXI $1.90
  • RGC $3.03
  • 52 Week High
  • UPXI $22.57
  • RGC $950.00
  • Technical
  • Relative Strength Index (RSI)
  • UPXI 53.76
  • RGC 60.43
  • Support Level
  • UPXI $9.50
  • RGC $476.79
  • Resistance Level
  • UPXI $11.40
  • RGC $560.00
  • Average True Range (ATR)
  • UPXI 1.49
  • RGC 123.87
  • MACD
  • UPXI -0.22
  • RGC 22.21
  • Stochastic Oscillator
  • UPXI 28.79
  • RGC 47.55

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: